首页 > 最新文献

American journal of translational research最新文献

英文 中文
Factors associated with early neurological deterioration after intravenous thrombolysis in acute cerebral infarction patients and establishment of a predictive model. 急性脑梗塞患者静脉溶栓后早期神经功能恶化的相关因素及预测模型的建立。
IF 1.7 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-15 eCollection Date: 2025-01-01 DOI: 10.62347/GIIG7402
Lingling Zhang, Jing Zhao, Boxin Kan, Qi Zhang

Objective: To analyze the factors influencing early neurological deterioration (END) after intravenous thrombolysis in patients with acute cerebral infarction (ACI) based on real-world data, and to establish a nomogram predictive model.

Methods: The clinical data of 148 ACI patients who received intravenous thrombolytic therapy within 4.5 hours of onset at Nantong Rici Hospital Affiliated with Yangzhou University, from January 2020 to December 2023, were retrospectively analyzed. Patient clinical and laboratory data were collected. Patients were divided into END and non-END groups according to whether they developed END after intravenous thrombolysis. Factors influencing the emergence of END were identified by univariate and multivariate logistic regression analyses. Risk factors were included to construct a nomogram risk predictive model, which was validated for efficacy. Model discrimination was assessed using the receiver operating characteristic curve (ROC) and the area under the ROC curve (AUC). Model fitting was evaluated using a calibration curve, and consistency was assessed by Hosmer-Lemeshow (HL) analysis.

Results: END occurred in 27 of 148 patients (18.24%). Multivariate analysis identified age, National Institute of Health stroke scale (NIHSS) score, fibrinogen, and the time from onset to thrombolysis as factors influencing END in ACI patients after thrombolysis. A nomogram predictive model was constructed based on the above indicators. The AUC for the model in predicting END in the training set and the test set was 0.994 (95% CI: 0.982-1.000) and 0.977 (95% CI: 0.940-1.000), respectively. HL test showed high goodness of fit (χ2 = 1.953, P = 0.982), and the calibration curve showed good agreement between the predicted and observed values.

Conclusion: Age, NIHSS score, fibrinogen, and time from onset to thrombolysis are significant factors influencing the development of END after thrombolysis in ACI patients. The predictive model based on these four variables demonstrates good discriminatory power and may assist in clinical decision-making.

{"title":"Factors associated with early neurological deterioration after intravenous thrombolysis in acute cerebral infarction patients and establishment of a predictive model.","authors":"Lingling Zhang, Jing Zhao, Boxin Kan, Qi Zhang","doi":"10.62347/GIIG7402","DOIUrl":"10.62347/GIIG7402","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the factors influencing early neurological deterioration (END) after intravenous thrombolysis in patients with acute cerebral infarction (ACI) based on real-world data, and to establish a nomogram predictive model.</p><p><strong>Methods: </strong>The clinical data of 148 ACI patients who received intravenous thrombolytic therapy within 4.5 hours of onset at Nantong Rici Hospital Affiliated with Yangzhou University, from January 2020 to December 2023, were retrospectively analyzed. Patient clinical and laboratory data were collected. Patients were divided into END and non-END groups according to whether they developed END after intravenous thrombolysis. Factors influencing the emergence of END were identified by univariate and multivariate logistic regression analyses. Risk factors were included to construct a nomogram risk predictive model, which was validated for efficacy. Model discrimination was assessed using the receiver operating characteristic curve (ROC) and the area under the ROC curve (AUC). Model fitting was evaluated using a calibration curve, and consistency was assessed by Hosmer-Lemeshow (HL) analysis.</p><p><strong>Results: </strong>END occurred in 27 of 148 patients (18.24%). Multivariate analysis identified age, National Institute of Health stroke scale (NIHSS) score, fibrinogen, and the time from onset to thrombolysis as factors influencing END in ACI patients after thrombolysis. A nomogram predictive model was constructed based on the above indicators. The AUC for the model in predicting END in the training set and the test set was 0.994 (95% CI: 0.982-1.000) and 0.977 (95% CI: 0.940-1.000), respectively. HL test showed high goodness of fit (χ<sup>2</sup> = 1.953, P = 0.982), and the calibration curve showed good agreement between the predicted and observed values.</p><p><strong>Conclusion: </strong>Age, NIHSS score, fibrinogen, and time from onset to thrombolysis are significant factors influencing the development of END after thrombolysis in ACI patients. The predictive model based on these four variables demonstrates good discriminatory power and may assist in clinical decision-making.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 1","pages":"247-253"},"PeriodicalIF":1.7,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11826171/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143431893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delta/pre-radiomics based on enhanced CT predicts complete response in locally advanced esophageal squamous cell carcinoma.
IF 1.7 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-15 eCollection Date: 2025-01-01 DOI: 10.62347/WQYO9624
Yan Zhu, Zhenzhong Zhang, Genji Bai, Lili Guo, Qingqing Xu, Lili Zhang, Yiping Gao, Shuangqing Chen

Objectives: This study aimed to evaluate the effectiveness of neoadjuvant immunochemotherapy (NIC) in patients diagnosed with locally advanced esophageal squamous cell carcinoma (LAESCC), by assessing the performance of models that utilize enhanced computed tomography (CT) images at the pre, post, and delta/pre group stages.

Methods: A total of 225 patients were included in our study and randomly divided into a training set (n = 157) and test set I (n = 68). In addition, we conducted a test set II involving 60 patients from another center. We obtained omics features from CT images before and after NIC. Then, the delta radiomics features were obtained by calculating the differences between the post and pre group features, which was then divided by the pre group features to obtain the delta/pre group. Imaging and clinicopathological data were collected in the two centers according to the same inclusion and exclusion criteria. The tumor regression grading (TRG) system was used according to the Japanese Esophageal Cancer (11th edition). Three sets of models were built and their performance was assessed using receiver operating characteristic (ROC) curve, confusion matrix, and calibration curve. The clinical utility of the model was evaluated through decision curve analysis and nomogram.

Results: The area under the curve value of the delta/pre-radiomics (Rad) score model was 0.876 in the training set and 0.827 and 0.749 in the two test sets, which was significantly higher than that in the pre and post Rad score models. The radiomics nomogram was constructed using Rad scores derived from the post model, delta/pre model, Ki67, P53, and the pathological stage of lymph node after neoadjuvant therapy (ypN), demonstrating robust performance. The internal correction curve (apparent) and the external correction curve (bias-corrected) exhibited negligible deviations from the ideal curve, thereby demonstrating a high level of similarity.

Conclusion: Nomogram, based on delta/pre-enhanced CT features and clinical risk indicators, is a non-invasive tool to predict therapeutic effects in patients with LAESCC after NIC.

{"title":"Delta/pre-radiomics based on enhanced CT predicts complete response in locally advanced esophageal squamous cell carcinoma.","authors":"Yan Zhu, Zhenzhong Zhang, Genji Bai, Lili Guo, Qingqing Xu, Lili Zhang, Yiping Gao, Shuangqing Chen","doi":"10.62347/WQYO9624","DOIUrl":"10.62347/WQYO9624","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to evaluate the effectiveness of neoadjuvant immunochemotherapy (NIC) in patients diagnosed with locally advanced esophageal squamous cell carcinoma (LAESCC), by assessing the performance of models that utilize enhanced computed tomography (CT) images at the pre, post, and delta/pre group stages.</p><p><strong>Methods: </strong>A total of 225 patients were included in our study and randomly divided into a training set (n = 157) and test set I (n = 68). In addition, we conducted a test set II involving 60 patients from another center. We obtained omics features from CT images before and after NIC. Then, the delta radiomics features were obtained by calculating the differences between the post and pre group features, which was then divided by the pre group features to obtain the delta/pre group. Imaging and clinicopathological data were collected in the two centers according to the same inclusion and exclusion criteria. The tumor regression grading (TRG) system was used according to the Japanese Esophageal Cancer (11th edition). Three sets of models were built and their performance was assessed using receiver operating characteristic (ROC) curve, confusion matrix, and calibration curve. The clinical utility of the model was evaluated through decision curve analysis and nomogram.</p><p><strong>Results: </strong>The area under the curve value of the delta/pre-radiomics (Rad) score model was 0.876 in the training set and 0.827 and 0.749 in the two test sets, which was significantly higher than that in the pre and post Rad score models. The radiomics nomogram was constructed using Rad scores derived from the post model, delta/pre model, Ki67, P53, and the pathological stage of lymph node after neoadjuvant therapy (ypN), demonstrating robust performance. The internal correction curve (apparent) and the external correction curve (bias-corrected) exhibited negligible deviations from the ideal curve, thereby demonstrating a high level of similarity.</p><p><strong>Conclusion: </strong>Nomogram, based on delta/pre-enhanced CT features and clinical risk indicators, is a non-invasive tool to predict therapeutic effects in patients with LAESCC after NIC.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 1","pages":"162-177"},"PeriodicalIF":1.7,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11826183/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143432178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identifcation of candidate biomarkers for polyarteritis nodosa using data-independent acquisition mass spectrometry.
IF 1.7 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-15 eCollection Date: 2025-01-01 DOI: 10.62347/QSRI6160
Huimin Ma, Xintian Cai, Delian Zhang, Qing Zhu, Ting Wu, Xiayire Aierken, Ayguzaili Ahmat, Shasha Liu, Nanfang Li

Objectives: Polyarteritis nodosa (PAN) is a rare autoimmune disease that can cause severe functional impairment. Early diagnosis and timely intervention are essential to reduce disease severity and improve outcomes.

Methods: Serum proteins from PAN patients and healthy controls were analyzed using data-independent acquisition mass spectrometry (DIA-MS), identifying 55 differentially expressed proteins. Validation was conducted on an independent set of 35 serum samples (10 healthy controls, 15 disease controls, and 10 PAN patients) to evaluate the diagnostic potential of selected biomarkers.

Results: Eighteen proteins showed significantly altered expression in PAN patients compared to controls. A diagnostic panel of seven proteins - AZGP1, F13B, LBP, RBP4, SERPINF1, PGLYRP2, and PPBP - was identified using the least absolute shrinkage and selection operator (LASSO) binary logistic regression model. This panel achieved an area under the receiver operating characteristic (ROC) curve of 0.994, effectively distinguishing PAN patients from controls.

Conclusion: By combining DIA-MS technology with the LASSO regression model, this study developed a 7-protein diagnostic panel, providing a highly accurate and efficient tool for PAN diagnosis.

{"title":"Identifcation of candidate biomarkers for polyarteritis nodosa using data-independent acquisition mass spectrometry.","authors":"Huimin Ma, Xintian Cai, Delian Zhang, Qing Zhu, Ting Wu, Xiayire Aierken, Ayguzaili Ahmat, Shasha Liu, Nanfang Li","doi":"10.62347/QSRI6160","DOIUrl":"10.62347/QSRI6160","url":null,"abstract":"<p><strong>Objectives: </strong>Polyarteritis nodosa (PAN) is a rare autoimmune disease that can cause severe functional impairment. Early diagnosis and timely intervention are essential to reduce disease severity and improve outcomes.</p><p><strong>Methods: </strong>Serum proteins from PAN patients and healthy controls were analyzed using data-independent acquisition mass spectrometry (DIA-MS), identifying 55 differentially expressed proteins. Validation was conducted on an independent set of 35 serum samples (10 healthy controls, 15 disease controls, and 10 PAN patients) to evaluate the diagnostic potential of selected biomarkers.</p><p><strong>Results: </strong>Eighteen proteins showed significantly altered expression in PAN patients compared to controls. A diagnostic panel of seven proteins - AZGP1, F13B, LBP, RBP4, SERPINF1, PGLYRP2, and PPBP - was identified using the least absolute shrinkage and selection operator (LASSO) binary logistic regression model. This panel achieved an area under the receiver operating characteristic (ROC) curve of 0.994, effectively distinguishing PAN patients from controls.</p><p><strong>Conclusion: </strong>By combining DIA-MS technology with the LASSO regression model, this study developed a 7-protein diagnostic panel, providing a highly accurate and efficient tool for PAN diagnosis.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 1","pages":"585-602"},"PeriodicalIF":1.7,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11826199/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143432014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical efficacy of soft-shelled turtle shell and salt moxibustion in improving kidney yang deficiency-type Laolin in middle-aged and elderly women.
IF 1.7 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-15 eCollection Date: 2025-01-01 DOI: 10.62347/ZRMU6808
Xiaobin Zhao, Lijuan Zhang, Xie Wu, Wenxia Huang, Bingyan Zhu, Zaixiang Tang

Objective: To evaluate the clinical efficacy of Soft-Shelled Turtle Shell and Salt Moxibustion in treating kidney yang deficiency-type Laolin in middle-aged and elderly women and assessing treatment impact on quality of life.

Methods: A retrospective analysis was conducted on 72 middle-aged and elderly female patients with kidney yang deficiency-type Laolin treated at Suzhou Hospital of Traditional Chinese Medicine between June 2023 and April 2024 (research group). Patients with the same condition who received only basic treatment and care served as the control group. The research group received Soft-Shelled Turtle Shell and Salt Moxibustion in addition to the control treatment. Outcomes including traditional Chinese medicine (TCM) syndrome scores, clinical efficacy, immunoglobulin M (IgM), immunoglobulin G (IgG), routine urine white blood cell count, urine bacterial counts, quality of life scores, and complication rates were compared between the two groups.

Results: The research group demonstrated significantly greater improvement in TCM syndrome scores, clinical efficacy, and urine bacterial counts compared to the control group (all P<0.05). Post-treatment IgM and IgG levels were also significantly higher in the research group (both P<0.05). Additionally, the research group exhibited a more pronounced reduction in urine white blood cell counts and achieved significantly higher quality of life scores (both P<0.05). The incidence of adverse reactions in the research group was lower than that in the control group (P<0.05). Patient satisfaction with care was notably higher in the research group (P<0.05).

Conclusion: Soft-Shelled Turtle Shell and Salt Moxibustion is highly effective in treating middle-aged and elderly female patients with kidney yang deficiency-type Laolin. It significantly improves TCM syndrome scores, immunoglobulin levels, urine bacterial counts, and routine urine white blood cell counts while enhancing patients' quality of life. The therapy is safe, with minimal and self-limiting adverse reactions, primarily mild skin irritation.

{"title":"Clinical efficacy of soft-shelled turtle shell and salt moxibustion in improving kidney yang deficiency-type Laolin in middle-aged and elderly women.","authors":"Xiaobin Zhao, Lijuan Zhang, Xie Wu, Wenxia Huang, Bingyan Zhu, Zaixiang Tang","doi":"10.62347/ZRMU6808","DOIUrl":"10.62347/ZRMU6808","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the clinical efficacy of Soft-Shelled Turtle Shell and Salt Moxibustion in treating kidney yang deficiency-type Laolin in middle-aged and elderly women and assessing treatment impact on quality of life.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 72 middle-aged and elderly female patients with kidney yang deficiency-type Laolin treated at Suzhou Hospital of Traditional Chinese Medicine between June 2023 and April 2024 (research group). Patients with the same condition who received only basic treatment and care served as the control group. The research group received Soft-Shelled Turtle Shell and Salt Moxibustion in addition to the control treatment. Outcomes including traditional Chinese medicine (TCM) syndrome scores, clinical efficacy, immunoglobulin M (IgM), immunoglobulin G (IgG), routine urine white blood cell count, urine bacterial counts, quality of life scores, and complication rates were compared between the two groups.</p><p><strong>Results: </strong>The research group demonstrated significantly greater improvement in TCM syndrome scores, clinical efficacy, and urine bacterial counts compared to the control group (all P<0.05). Post-treatment IgM and IgG levels were also significantly higher in the research group (both P<0.05). Additionally, the research group exhibited a more pronounced reduction in urine white blood cell counts and achieved significantly higher quality of life scores (both P<0.05). The incidence of adverse reactions in the research group was lower than that in the control group (P<0.05). Patient satisfaction with care was notably higher in the research group (P<0.05).</p><p><strong>Conclusion: </strong>Soft-Shelled Turtle Shell and Salt Moxibustion is highly effective in treating middle-aged and elderly female patients with kidney yang deficiency-type Laolin. It significantly improves TCM syndrome scores, immunoglobulin levels, urine bacterial counts, and routine urine white blood cell counts while enhancing patients' quality of life. The therapy is safe, with minimal and self-limiting adverse reactions, primarily mild skin irritation.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 1","pages":"406-415"},"PeriodicalIF":1.7,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11826195/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143432109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficiency of evidence-based collaborative nursing on complications, negative emotions and quality of live in radical prostatectomy.
IF 1.7 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-15 eCollection Date: 2025-01-01 DOI: 10.62347/DZDL1914
Xiujing Wu, Xiaoying Zang

Objective: To evaluate the effectiveness of evidence-based collaborative nursing in reducing complications, alleviating negative emotions, and improving the quality of life in patients undergoing radical prostatectomy.

Methods: In this retrospective study, Sixty-three patients who underwent surgery for prostate cancer between September 2021 and August 2022 were included as the control group, while 75 patients hospitalized between September 2022 and August 2023 were selected as the observation group. All these patients were treated at Tianjin Medical University General Hospital. The control group received routine nursing care, while the observation group received evidence-based collaborative nursing in addition to standard care. Complications, emotional state, self-care ability, fear of disease progression, quality of life, urodynamic index and the satisfaction with care were compared and analyzed between the two groups.

Results: The observation group experienced significantly fewer complications than the control group (P<0.05). After intervention, both groups showed a significant reduction in negative emotional scores and an increase in positive emotional scores compared to pre-intervention (all P<0.05), with the observation group demonstrating more pronounced alterations (all P<0.05). Self-care ability scores in both groups improved significantly post-intervention (P<0.05), with the observation group showing higher scores than the control group (P<0.05). Scores related to fear of disease progression were significantly lower in both groups post-intervention, with the observation group showing a greater reduction (P<0.05). Quality of life scores in the functional dimension improved and symptom scores decreased in both groups post-intervention (P<0.05), with the observation group showing better outcomes than the control group (P<0.05). Urodynamic indices, including maximum urine flow, maximum urethral closure, and maximum bladder capacity, improved significantly in both groups post-intervention (P<0.05), with the observation group outperforming the control group (P<0.05). Additionally, the observation group reported higher satisfaction with nursing care compared to the control group (P<0.05).

Conclusion: Evidence-based collaborative caring significantly improves emotional well-being, enhances self-care ability and quality of life, and reduces postoperative complications in patients undergoing radical prostatectomy. This approach holds great potential for broader clinical application.

{"title":"Efficiency of evidence-based collaborative nursing on complications, negative emotions and quality of live in radical prostatectomy.","authors":"Xiujing Wu, Xiaoying Zang","doi":"10.62347/DZDL1914","DOIUrl":"10.62347/DZDL1914","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the effectiveness of evidence-based collaborative nursing in reducing complications, alleviating negative emotions, and improving the quality of life in patients undergoing radical prostatectomy.</p><p><strong>Methods: </strong>In this retrospective study, Sixty-three patients who underwent surgery for prostate cancer between September 2021 and August 2022 were included as the control group, while 75 patients hospitalized between September 2022 and August 2023 were selected as the observation group. All these patients were treated at Tianjin Medical University General Hospital. The control group received routine nursing care, while the observation group received evidence-based collaborative nursing in addition to standard care. Complications, emotional state, self-care ability, fear of disease progression, quality of life, urodynamic index and the satisfaction with care were compared and analyzed between the two groups.</p><p><strong>Results: </strong>The observation group experienced significantly fewer complications than the control group (<i>P</i><0.05). After intervention, both groups showed a significant reduction in negative emotional scores and an increase in positive emotional scores compared to pre-intervention (all <i>P</i><0.05), with the observation group demonstrating more pronounced alterations (all <i>P</i><0.05). Self-care ability scores in both groups improved significantly post-intervention (P<0.05), with the observation group showing higher scores than the control group (P<0.05). Scores related to fear of disease progression were significantly lower in both groups post-intervention, with the observation group showing a greater reduction (P<0.05). Quality of life scores in the functional dimension improved and symptom scores decreased in both groups post-intervention (P<0.05), with the observation group showing better outcomes than the control group (P<0.05). Urodynamic indices, including maximum urine flow, maximum urethral closure, and maximum bladder capacity, improved significantly in both groups post-intervention (P<0.05), with the observation group outperforming the control group (P<0.05). Additionally, the observation group reported higher satisfaction with nursing care compared to the control group (P<0.05).</p><p><strong>Conclusion: </strong>Evidence-based collaborative caring significantly improves emotional well-being, enhances self-care ability and quality of life, and reduces postoperative complications in patients undergoing radical prostatectomy. This approach holds great potential for broader clinical application.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 1","pages":"349-357"},"PeriodicalIF":1.7,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11826179/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143432212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of blood purification combined with antibiotics on CC-16 and SP-D levels and prognosis in patients with severe acute pancreatitis complicated by acute respiratory distress syndrome.
IF 1.7 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-15 eCollection Date: 2025-01-01 DOI: 10.62347/LVRO1003
Jing Guo, Bin Wu, Yuee Liu, Biao Zhu, Furong Lu

Objective: To investigate the effects of continuous blood purification (CBP) combined with antibiotics on pulmonary surfactant protein D (SP-D), Clara cell protein-16 (CC-16), and prognosis in patients with severe acute pancreatitis (SAP) complicated by acute respiratory distress syndrome (ARDS).

Methods: A total of 128 patients with SAP and ARDS treated at Fudan University Shanghai Cancer Center from June 2021 to June 2023 were enrolled. Patients were divided into two groups: a control group (n=64) receiving routine treatment (gastrointestinal decompression, somatostatin administration, nutritional support, correction of water-electrolyte imbalance, and microcirculation improvement) and an observation group (n=64) treated with CBP combined with antibiotics. Clinical data, including the pancreatic edema resolution time, ventilator weaning time, and hospital stay, were compared between groups. Additional comparisons included intra-abdominal pressure (IAP), blood amylase (AMS), urinary amylase (UAMY), inflammatory markers [tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), interleukin-1β (IL-1β)], respiratory mechanics indices [airway peak pressure (Peak), airway plateau pressure (Plat), respiratory rate (F)], and blood oxygen levels [partial pressure of arterial oxygen (PaO2), PaO2/fraction of inspired oxygen (FiO2)] before and after treatment.

Results: The observation group demonstrated significantly better outcomes compared to the control group in terms of pancreatic edema resolution time, ventilator weaning time, hospital stay, and other indicators (all P<0.05). The 28-day mortality rate in the observation group was significantly lower than in the control group (P<0.05). Post-treatment levels of CC-16, SP-D, Peak, Plat, and other indicators improved significantly in both groups compared to baseline (all P<0.05). The observation group exhibited significantly greater improvements in PaO2 and PaO2/FiO2 compared to the control group (all P<0.05).

Conclusion: CBP combined with antibiotics significantly improves clinical symptoms, reduces inflammatory markers, enhances prognosis, and lowers mortality rates in patients with SAP complicated by ARDS.

{"title":"Effect of blood purification combined with antibiotics on CC-16 and SP-D levels and prognosis in patients with severe acute pancreatitis complicated by acute respiratory distress syndrome.","authors":"Jing Guo, Bin Wu, Yuee Liu, Biao Zhu, Furong Lu","doi":"10.62347/LVRO1003","DOIUrl":"10.62347/LVRO1003","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the effects of continuous blood purification (CBP) combined with antibiotics on pulmonary surfactant protein D (SP-D), Clara cell protein-16 (CC-16), and prognosis in patients with severe acute pancreatitis (SAP) complicated by acute respiratory distress syndrome (ARDS).</p><p><strong>Methods: </strong>A total of 128 patients with SAP and ARDS treated at Fudan University Shanghai Cancer Center from June 2021 to June 2023 were enrolled. Patients were divided into two groups: a control group (n=64) receiving routine treatment (gastrointestinal decompression, somatostatin administration, nutritional support, correction of water-electrolyte imbalance, and microcirculation improvement) and an observation group (n=64) treated with CBP combined with antibiotics. Clinical data, including the pancreatic edema resolution time, ventilator weaning time, and hospital stay, were compared between groups. Additional comparisons included intra-abdominal pressure (IAP), blood amylase (AMS), urinary amylase (UAMY), inflammatory markers [tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), interleukin-1β (IL-1β)], respiratory mechanics indices [airway peak pressure (Peak), airway plateau pressure (Plat), respiratory rate (F)], and blood oxygen levels [partial pressure of arterial oxygen (PaO<sub>2</sub>), PaO<sub>2</sub>/fraction of inspired oxygen (FiO<sub>2</sub>)] before and after treatment.</p><p><strong>Results: </strong>The observation group demonstrated significantly better outcomes compared to the control group in terms of pancreatic edema resolution time, ventilator weaning time, hospital stay, and other indicators (all P<0.05). The 28-day mortality rate in the observation group was significantly lower than in the control group (P<0.05). Post-treatment levels of CC-16, SP-D, Peak, Plat, and other indicators improved significantly in both groups compared to baseline (all P<0.05). The observation group exhibited significantly greater improvements in PaO<sub>2</sub> and PaO<sub>2</sub>/FiO<sub>2</sub> compared to the control group (all P<0.05).</p><p><strong>Conclusion: </strong>CBP combined with antibiotics significantly improves clinical symptoms, reduces inflammatory markers, enhances prognosis, and lowers mortality rates in patients with SAP complicated by ARDS.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 1","pages":"429-439"},"PeriodicalIF":1.7,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11826176/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143432189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The molecular mechanism underlying angiogenesis in a mouse model of chronic kidney disease after ischemic stroke.
IF 1.7 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-15 eCollection Date: 2025-01-01 DOI: 10.62347/ZTSX4782
Fang Wang, Liangxiang Lu, Jialun Feng, Jinhua Zheng, Zefeng Wei, Ziqiang Wang

Objectives: The study aims to establish a reliable chronic kidney disease (CKD) mouse model by examining the effects of an adenine-containing diet on renal function and pathology. It also explores the impact of CKD on motor function and infarct volume following cerebral infarction and investigates the role of calcium in modulating the AMPK/SIRT1/HIF1-α signaling pathways.

Method: The CKD mouse model was induced through an adenine-enriched diet. Renal function impairment was assessed by analyzing blood samples for creatinine and blood urea nitrogen levels at 0 and 6 weeks. Pathologic changes in renal tissue were examined. The study also evaluated motor function, infarct volume, survival rates, body weight changes, and functional assessments. Additionally, cerebral cortex angiogenesis was assessed in the context of ischemic stroke.

Result: The CKD mouse model showed significant renal tissue alterations, including luminal dilation, glomerular hypertrophy, fibrosis, and inflammatory infiltration. There was a notable reduction in angiogenic markers in the CKD group compared to controls. The study also found increased cerebral calcium levels and altered expression of AMPK, SIRT1, HIF1-α, and VEGF in the CKD group.

Conclusions: The research successfully created the CKD mouse model and emphasized the disease's many effects, including its influence on neurological disorders. The results provide an understanding of the molecular processes behind changes brought on by CKD and may have consequences for angiogenesis and signaling pathway-focused therapeutic approaches.

{"title":"The molecular mechanism underlying angiogenesis in a mouse model of chronic kidney disease after ischemic stroke.","authors":"Fang Wang, Liangxiang Lu, Jialun Feng, Jinhua Zheng, Zefeng Wei, Ziqiang Wang","doi":"10.62347/ZTSX4782","DOIUrl":"10.62347/ZTSX4782","url":null,"abstract":"<p><strong>Objectives: </strong>The study aims to establish a reliable chronic kidney disease (CKD) mouse model by examining the effects of an adenine-containing diet on renal function and pathology. It also explores the impact of CKD on motor function and infarct volume following cerebral infarction and investigates the role of calcium in modulating the AMPK/SIRT1/HIF1-α signaling pathways.</p><p><strong>Method: </strong>The CKD mouse model was induced through an adenine-enriched diet. Renal function impairment was assessed by analyzing blood samples for creatinine and blood urea nitrogen levels at 0 and 6 weeks. Pathologic changes in renal tissue were examined. The study also evaluated motor function, infarct volume, survival rates, body weight changes, and functional assessments. Additionally, cerebral cortex angiogenesis was assessed in the context of ischemic stroke.</p><p><strong>Result: </strong>The CKD mouse model showed significant renal tissue alterations, including luminal dilation, glomerular hypertrophy, fibrosis, and inflammatory infiltration. There was a notable reduction in angiogenic markers in the CKD group compared to controls. The study also found increased cerebral calcium levels and altered expression of AMPK, SIRT1, HIF1-α, and VEGF in the CKD group.</p><p><strong>Conclusions: </strong>The research successfully created the CKD mouse model and emphasized the disease's many effects, including its influence on neurological disorders. The results provide an understanding of the molecular processes behind changes brought on by CKD and may have consequences for angiogenesis and signaling pathway-focused therapeutic approaches.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 1","pages":"528-537"},"PeriodicalIF":1.7,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11826205/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143432203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Small cell lung cancer and prostate cancer cells with varying neuroendocrine differentiation markers show sensitivity to imipridone ONC201/TIC10.
IF 1.7 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-15 eCollection Date: 2025-01-01 DOI: 10.62347/IBUS3598
Elizabeth Ding, Maximillian Pinho-Schwermann, Shengliang Zhang, Connor Purcell, Wafik S El-Deiry

Objectives: To investigate whether neuroendocrine differentiation (NED) markers, activation of the integrated stress response (ISR), and TRAIL pathway alter neuroendocrine tumor (NET) cell death and ONC201 sensitivity.

Methods: We conducted cell viability assays to determine ONC201 sensitivity. Western blot analysis was performed to evaluate NED, ISR, and TRAIL pathway markers. Expression levels of NED markers were compared between cell lines with and without BRN2 overexpression.

Results: Prostate cancer (PCa) and small cell lung cancer (SCLC) cell lines (N = 6) were sensitive to ONC201. Endogenous NET marker levels varied across PCa and SCLC cells. Transient BRN2 overexpression slightly reduced some NET markers while maintaining the sensitivity of PCa cells to ONC201.

Conclusions: PCa cell lines exhibit sensitivity to ONC201, with variability of NED features. These findings are relevant to the design of future studies evaluating imipridone efficacy in PCa and suggest that non-NET patients could be included in such studies.

{"title":"Small cell lung cancer and prostate cancer cells with varying neuroendocrine differentiation markers show sensitivity to imipridone ONC201/TIC10.","authors":"Elizabeth Ding, Maximillian Pinho-Schwermann, Shengliang Zhang, Connor Purcell, Wafik S El-Deiry","doi":"10.62347/IBUS3598","DOIUrl":"10.62347/IBUS3598","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate whether neuroendocrine differentiation (NED) markers, activation of the integrated stress response (ISR), and TRAIL pathway alter neuroendocrine tumor (NET) cell death and ONC201 sensitivity.</p><p><strong>Methods: </strong>We conducted cell viability assays to determine ONC201 sensitivity. Western blot analysis was performed to evaluate NED, ISR, and TRAIL pathway markers. Expression levels of NED markers were compared between cell lines with and without BRN2 overexpression.</p><p><strong>Results: </strong>Prostate cancer (PCa) and small cell lung cancer (SCLC) cell lines (N = 6) were sensitive to ONC201. Endogenous NET marker levels varied across PCa and SCLC cells. Transient BRN2 overexpression slightly reduced some NET markers while maintaining the sensitivity of PCa cells to ONC201.</p><p><strong>Conclusions: </strong>PCa cell lines exhibit sensitivity to ONC201, with variability of NED features. These findings are relevant to the design of future studies evaluating imipridone efficacy in PCa and suggest that non-NET patients could be included in such studies.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 1","pages":"104-115"},"PeriodicalIF":1.7,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11826210/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143432197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Body shape index: an index for early target organ damage in hypertension.
IF 1.7 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-15 eCollection Date: 2025-01-01 DOI: 10.62347/FMEB5040
Wangjiang Wei, Ping Ding

Objective: To investigate the relationship between obesity-related indices and target organ damage in hypertension, with the goal of improving damage prevention and treatment strategies.

Methods: This retrospective study included 150 hypertension cases from January 2022 to December 2023 treated at Beijing Ditan Hospital, including 72 cases of isolated hypertension, 48 with hypertension complicated by kidney damage, 47 with hypertension and left ventricular hypertrophy, and 44 with hypertension and carotid atherosclerosis. Clinical indicators and obesity-related indices were collected to analyze their correlation with target organ damage in hypertension.

Results: A Body Shape Index (ABSI) (OR: 1.003 [1.001-1.913], P=0.007), BMI (OR: 1.054 [1.005-1.694], P=0.023), and BRI (OR: 0.562 [0.287-0.934], P=0.034) were independently associated with hypertensive kidney damage. Age (OR: 1.037 [1.000-1.635], P=0.034), ABSI (OR: 0.901 [0.882-0.998], P=0.034), and blood pressure grading (OR: 1.473 [1.175-1.845], P=0.002) were independent risk factors for hypertensive left ventricular hypertrophy. ABSI (OR: 1.012 [1.001-1.623], P=0.032) and smoking history (OR: 0.892 [0.781-0.998], P=0.021) were independent risk factors for hypertensive carotid artery plaque formation.

Conclusion: ABSI is an independent risk factor for target organ damage in hypertension.

{"title":"Body shape index: an index for early target organ damage in hypertension.","authors":"Wangjiang Wei, Ping Ding","doi":"10.62347/FMEB5040","DOIUrl":"10.62347/FMEB5040","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the relationship between obesity-related indices and target organ damage in hypertension, with the goal of improving damage prevention and treatment strategies.</p><p><strong>Methods: </strong>This retrospective study included 150 hypertension cases from January 2022 to December 2023 treated at Beijing Ditan Hospital, including 72 cases of isolated hypertension, 48 with hypertension complicated by kidney damage, 47 with hypertension and left ventricular hypertrophy, and 44 with hypertension and carotid atherosclerosis. Clinical indicators and obesity-related indices were collected to analyze their correlation with target organ damage in hypertension.</p><p><strong>Results: </strong>A Body Shape Index (ABSI) (OR: 1.003 [1.001-1.913], P=0.007), BMI (OR: 1.054 [1.005-1.694], P=0.023), and BRI (OR: 0.562 [0.287-0.934], P=0.034) were independently associated with hypertensive kidney damage. Age (OR: 1.037 [1.000-1.635], P=0.034), ABSI (OR: 0.901 [0.882-0.998], P=0.034), and blood pressure grading (OR: 1.473 [1.175-1.845], P=0.002) were independent risk factors for hypertensive left ventricular hypertrophy. ABSI (OR: 1.012 [1.001-1.623], P=0.032) and smoking history (OR: 0.892 [0.781-0.998], P=0.021) were independent risk factors for hypertensive carotid artery plaque formation.</p><p><strong>Conclusion: </strong>ABSI is an independent risk factor for target organ damage in hypertension.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 1","pages":"200-210"},"PeriodicalIF":1.7,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11826200/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143432104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of the Oxford Arthroplasty Early Recovery Score for patients undergoing Joint arthroplasty.
IF 1.7 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-15 eCollection Date: 2025-01-01 DOI: 10.62347/YMBI7245
Ying Pu, Lu Zhang, Rui Zhang, Sha Luo, Keqin Hu

Objective: To translate and adapt the Oxford Arthroplasty Early Recovery Score into Chinese, creating an assessment tool suitable for the early postoperative recovery of patients undergoing Joint arthroplasty.

Methods: By adopting the convenience sampling method, 200 patients who had undergone hip arthroplasty at The Affiliated Hospital of North Sichuan Medical College between February 2022 and February 2023, with a two-week follow-up, were selected as the research subjects. Clinical and disease-related data were collected, and a preliminarily analysis was conducted to identify factors influencing early postoperative recovery.

Results: A total of 200 questionnaires were distributed, and all were retrieved, with no invalid questionnaires excluded, resulting in an effective response rate of 100%. The total score of the early postoperative recovery quality of patients averaged (-2.49±12.32) points, the average score of pain sensation was (0.86±5.16) points, the average physical function was (-3.72±4.07) points, and the average psychosocial status was (-2.00±5.02) points. Statistical analysis showed that gender (P=0.004), age (P<0.0001), per capita monthly household income (P<0.0001), course of disease (P<0.0001), and BMI (P=0.006) had a significant effect on early postoperative recovery.

Conclusion: The Chinese version of the OARS scale has good reliability and validity, making it a useful tool for assessing limb function recovery and physical symptom perception in the early postoperative stage for patients undergoing joint arthroplasty.

{"title":"Application of the Oxford Arthroplasty Early Recovery Score for patients undergoing Joint arthroplasty.","authors":"Ying Pu, Lu Zhang, Rui Zhang, Sha Luo, Keqin Hu","doi":"10.62347/YMBI7245","DOIUrl":"10.62347/YMBI7245","url":null,"abstract":"<p><strong>Objective: </strong>To translate and adapt the Oxford Arthroplasty Early Recovery Score into Chinese, creating an assessment tool suitable for the early postoperative recovery of patients undergoing Joint arthroplasty.</p><p><strong>Methods: </strong>By adopting the convenience sampling method, 200 patients who had undergone hip arthroplasty at The Affiliated Hospital of North Sichuan Medical College between February 2022 and February 2023, with a two-week follow-up, were selected as the research subjects. Clinical and disease-related data were collected, and a preliminarily analysis was conducted to identify factors influencing early postoperative recovery.</p><p><strong>Results: </strong>A total of 200 questionnaires were distributed, and all were retrieved, with no invalid questionnaires excluded, resulting in an effective response rate of 100%. The total score of the early postoperative recovery quality of patients averaged (-2.49±12.32) points, the average score of pain sensation was (0.86±5.16) points, the average physical function was (-3.72±4.07) points, and the average psychosocial status was (-2.00±5.02) points. Statistical analysis showed that gender (P=0.004), age (P<0.0001), per capita monthly household income (P<0.0001), course of disease (P<0.0001), and BMI (P=0.006) had a significant effect on early postoperative recovery.</p><p><strong>Conclusion: </strong>The Chinese version of the OARS scale has good reliability and validity, making it a useful tool for assessing limb function recovery and physical symptom perception in the early postoperative stage for patients undergoing joint arthroplasty.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 1","pages":"338-348"},"PeriodicalIF":1.7,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11826187/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143432129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American journal of translational research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1